Holen Sie sich die Stockscreener-App
375.43
0.41%
-1.54
Handel nachbörslich:
375.43
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Crysvita Market Is Going to Boom | Kyowa Kirin • Amgen • Sanofi • Takeda Pharmaceutical - openPR.com
Rep. David Taylor Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
SNL mocks Amgen’s Otezla in bizarre sketch featuring Ryan Gosling - Medical Marketing and Media
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen
9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus - TradingView
Swiss National Bank Sells 77,600 Shares of Amgen Inc. $AMGN - MarketBeat
The first KRAS drugs have been sluggish on the market. Will the next generation fare better? - Pharma Voice
Therapeutics Companies Exceed Q4 2025 Revenue Estimates, Led by Novavax and AmgenNews and Statistics - IndexBox
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks - Finviz
First Trust Advisors LP Sells 46,048 Shares of Amgen Inc. $AMGN - MarketBeat
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Globe and Mail
Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Motley Fool
Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate - Yahoo Finance
Vinva Investment Management Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Korea Investment CORP Sells 22,072 Shares of Amgen Inc. $AMGN - MarketBeat
Blair William & Co. IL Reduces Position in Amgen Inc. $AMGN - MarketBeat
B. Metzler seel. Sohn & Co. AG Has $14.48 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation After Rocatinlimab Trial Halt And Pipeline Setback - simplywall.st
56,522 Shares in Amgen Inc. $AMGN Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat
Neuberger Berman Group LLC Sells 3,315 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
3,603 Shares in Amgen Inc. $AMGN Purchased by Integrity Advisory Solutions LLC - MarketBeat
Pitcairn Co. Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Wearable Injectors Market Set to Witness Rapid Growth Through - openPR.com
Edgar Lomax Co. VA Sells 29,960 Shares of Amgen Inc. $AMGN - MarketBeat
American Century Companies Inc. Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Xgeva Market Booming with Rapid Growth Through 2033 | Amgen • Novartis • Pfizer • Eli Lilly - openPR.com
AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE - Amgen
Kyowa Kirin discontinues rocatinlimab trials due to safety issues - bioworld.com
Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities - Yahoo Finance
Why Is Amgen (AMGN) Up 3.6% Since Last Earnings Report? - Yahoo Finance
Amgen Inc Stock (AMGN) Moved Down by 3.08% on Mar 5: Key Drivers Unveiled - TradingKey
Amgen Inc. (NASDAQ:AMGN) Plans Quarterly Dividend of $2.52 - MarketBeat
Amgen: Wait For A Better Entry Point (Rating Downgrade) (NASDAQ:AMGN) - Seeking Alpha
ARK Investment Management LLC Sells 10,668 Shares of Amgen Inc. $AMGN - MarketBeat
CI Investments Inc. Has $6.34 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Mix And Valuation Gap - simplywall.st
Is Amgen (AMGN) Pricing Reflect Its Recent 24% One Year Share Price Return - Yahoo Finance
Amgen (AMGN) Maintains Quarterly Dividend of $2.52 Per Share - GuruFocus
Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15 - marketscreener.com
AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND - Amgen
Amgen announces 2026 second quarter dividend - marketscreener.com
Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial - TipRanks
Dimensional Fund Advisors Boosts Amgen Holdings - National Today
Smith Chas P & Associates PA Cpas Sells 47,455 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Victory Capital Management Inc. - MarketBeat
Mcdonald Partners LLC Decreases Holdings in Amgen Inc. $AMGN - MarketBeat
GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.
Dimensional Fund Advisors LP Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Is It Time To Reassess Amgen (AMGN) After Its Strong Multi Year Share Price Run? - simplywall.st
AMGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Amgen, Inc. Hits New 52-Week High of USD 390.14 - Markets Mojo
Amgen Inc. (AMGN) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Amgen EVP Sold $20.77M In Company Stock - Benzinga
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Amgen stock forecast for 2030: $6B patent exposure challenges $500 level - Traders Union
Fisher Asset Management LLC Acquires 375,463 Shares of Amgen Inc. $AMGN - MarketBeat
IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook - Stocktwits
Amgen (NASDAQ:AMGN) Sets New 1-Year HighShould You Buy? - MarketBeat
Amgen (NASDAQ:AMGN) Hits Annual High Within The Nasdaq 100 Index Rally - Kalkine Media
Amgen Touts Broad Portfolio Momentum, MariTide Milestones and Repatha Access Push at TD Cowen Conf - MarketBeat
Amgen Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S Revenue Breakdown – NEO:AMGN - TradingView
How North Carolina Attracted Amgen and Roche To Become a Next-Gen Obesity Drug Production Hotspot - BioSpace
Amgen (AMGN) EVP Esteban Santos exercises options and sells 54,792 shares - Stock Titan
Amgen at TD Cowen Conference: Strategic Growth and Challenges - Investing.com India
Amgen Is Up 35% in the Last 6 Months. Here’s Where the Stock Could Go in 2026 - TIKR.com
Amgen’s Phase 3 Gout Trial Pits Subcutaneous Pegloticase Against IV Dosing - TipRanks
1.32%
2.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):